Bone Repair Articles & Analysis
26 news found
She earned her Bachelor of Science degree in biomedical engineering from the University of Iowa and is an inventor on a U.S. patent for a bone plate system for repair of proximal humeral fracture. “It is an exciting time to be joining Daxor as we prepare to submit our next generation systems in preparation for the most important technology launch for the ...
Several peptides have been shown to support and stimulate the bone healing response and have been proposed as therapeutic vehicles for clinical use. ...
BELLEVUE, Wash., Oct. 6, 2022 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced participation in the Industry Sessions of the Orthopaedic Trauma Association (OTA) 38th Annual Meeting, Oct. 12-15 in Tampa, Fl, highlighting the expanding use of the CurvaFix® IM Implant by industry-leading surgeons for ...
BELLEVUE, Wash., Sept. 28, 2022 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the addition of three new members to its Surgeon Advisory Board. ...
This experiment will examine the biomaterial's osteoconductivity when used in a microgravity environment where bone density and the ability to regenerate new bone tissue is significantly compromised. ...
KLISBio’s first product in pipeline is SILKBridge®, a silk fibroin absorbable medical device for peripheral nerve repair. The promising results of the first clinical study on SILKBridge® conducted by Prof. ...
ByKLISBio
Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its investigational P-15L Bone Graft for the treatment of degenerative disc disease (DDD). ...
Among the most innovative MedTech emerging companies, KLISBio is keen to deal-make and establish strong relations with active investors and paramount players in the life science and regenerative medicine space, aiming to contribute to the advancement of the whole industry with SILKBridge®, KLISBio’s first product in pipeline for peripheral nerve repair. ...
ByKLISBio
KLISBio is committed to contributing to the advancement of orthopedics with SILKBridge®, its first product in pipeline intended for the surgical repair of digital nerves. SILKBridge®, a silk-based graft, is a tissue-engineered technology made of pure silk fibroin. ...
ByKLISBio
Among the best innovators in orthopedics, biologics and regenerative medicine participating in CG Musculoskeletal Conference, KLISBio is open to expand its network and build strong relations with investors and industry leaders, in the attempt to move forward the current standard of care in peripheral nerve repair with SILKBridge®, KLISBio’s first product in pipeline for ...
ByKLISBio
KLISBio, a clinical-stage company leading a revolution in restorative surgical procedures and tissue engineering, is willing to connect with investors and strategic partners, with the purpose of moving science forward and advancing innovation in the life science and healthcare domain with SILKBridge®, KLISBio’s first product in pipeline for peripheral nerve repair. ...
ByKLISBio
Among the most innovative MedTech emerging companies, KLISBio is keen to deal-make and establish strong relations with active investors and paramount players in the life science and regenerative medicine space, aiming to contribute to the advancement of the whole industry with SILKBridge®, KLISBio’s first product in pipeline for peripheral nerve repair. ...
ByKLISBio
Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bone repair, announced today the completion of enrollment of the ASPIRE study, a pivotal U.S. ...
Since the last few decades, biomedical materials have been extensively used in a lot of medical applications, such as tissue scaffolds, wound care, regenerative dentistry, bone graft, implantable devices and cosmetic surgery. Earlier this month, T,C&A Lab, a branch of Alfa Chemistry, announces to provide biomedical material testing service for customers worldwide who would ...
It is intended for the surgical repair of peripheral nerve discontinuities to support regeneration across the defect and is anticipated to be available for clinical use in 2023. The company is also working on silk technologies focused on vascular grafting, rotator cuff repair, bone grafting and drug release which they plan to launch between ...
ByKLISBio
Among the company’s developing portfolio of products is SILKBridge®, a first-to-market, silk-based graft for peripheral nerve repair, which is anticipated to be available for clinical use in 2023. ...
ByKLISBio
That’s a driving force behind KLISBio’s SILKBridge®, a first-to-market solution for peripheral nerve repair. KLISBio will introduce SILKBridge® to attendees at the American Association for Hand Surgeons Annual Meeting Jan. 12-15, 2022. ...
ByKLISBio
Surgical procedures included amputation, removal of exostosis, midfoot bone removal, Achilles’ tendon repair, bunionectomy, or an elevating osteotomy with primary closure of the wound. ...
Cerapedics Inc., a private ortho-biologics company dedicated to enhancing the science of bone repair, announced today that results of a study to evaluate the cost-effectiveness of i-FACTOR Peptide Enhanced Bone Graft compared to autograft for patients undergoing ACDF surgery were recently published in ClinicoEconomics and Outcomes Research (July ...
-based biopharmaceutical company has discovered and patented a novel molecular pathway intended to treat metastatic bone lesions Latest patent issuance follows previous patents for methods in stimulating bone growth, promote controlled bone creation and repair of large segmental bone defects using ZetaMet™ ...